|Articles|February 1, 1996

The American Journal of Managed Care

  • February 1996
  • Volume 2
  • Issue 2

Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products

Download PDF: Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products

Articles in this issue

about 30 years ago

Adapting Pharmacy Services to the Needs of Managed Care

about 30 years ago

Risk-Adjusted Physician and Hospital Profiling: The Keys to Managed Care Success

about 30 years ago

Correspondence regarding, "Partial Medication Compliance: The Enigma in Poor Medical Outcomes"

about 30 years ago

Advanced Practice Nurses and Success of Organized Delivery Systems

about 30 years ago

Pharmacoeconomic Impact of Injectable Sumatriptan on Migraine-Associated Healthcare Costs

about 30 years ago

Estimated Costs of Treating Stress Urinary Incontinence in Elderly Women According to the AHCPR Clinical Practice Guidelines

about 30 years ago

Ethical Issues in Managed Care

about 30 years ago

The Economics of Compliance in Managed Healthcare Settings

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text